Tiziana Life Sci Plc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tiziana life sci plc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tiziana Life Sci Plc Today - Breaking & Trending Today

Investegate |Tiziana Life Sci PLC Announcements | Tiziana Life Sci PLC: Significant Immunomodulation effects on Biomarkers

Investegate announcements from Tiziana Life Sci PLC, Significant Immunomodulation effects on Biomarkers ....

United States , United Kingdom , Kunwar Shailubhai , Howardl Weiner , Gabriele Cerrone , Tanuja Chitnis , Tiziana Life Sciences , Professor Of Neurology At Harvard Medical School , Scientific Advisory Board Of Tiziana Life Sciences , Harvard Medical School , Redchip Companies Inc , Inflammatory Biomarkers , Nasally Administered Foralumab , Life Sciences , Scientific Advisory Board , Harvard Medical , Investegate Announcements , Investegate Company Announcements , Tiziana Life Sci Plc , Egulatory News Service , Egulatory News Service And Regulatory , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , கேப்ரியல் சிஇஆர்ஆர்ஓஎன்இ , தனுஜா சிட்னிஸ் , ப்ரொஃபெஸர் ஆஃப் நரம்பியல் இல் ஹார்வர்ட் மருத்துவ பள்ளி ,

Investegate |Tiziana Life Sci PLC Announcements | Tiziana Life Sci PLC: APPOINTMENT OF DIRECTOR

5 February 2021
NEW YORK and LONDON - February 5, 2021 (GLOBE NEWSWIRE) - Tiziana Life Sciences plc (NASDAQ: TLSA / LSE: TILS) ( Tiziana or the Company ), a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, today announces the appointment of Dr Thomas Adams, Ph.D. as an executive director.
Dr Adams will assume the position of Head of Drug Development with immediate effect and his executive role will be to manage and oversee all matters relating to the Company s pre-clinical and clinical drug development programs and associated intellectual property.
Dr Thomas H Adams (age: 78)
Dr. Adams holds a Ph.D. in Biochemistry from the University of California, Riverside. The Board believes that Dr. Adams executive leadership and the extensive healthcare expertise he has developed makes Dr. Adams ideally qualified to serve as an additional director of the Company. ....

United States , United Kingdom , City Of , Thomas Adams , Gabriele Cerrone , Thomash Adams , Clearbridge Biophotonics Inc , Cardiff Oncology Inc , University Of California , Genta Inc , Hepion Pharmaceuticals Inc , International Inc , Tiziana Life Sciences , Company Milciclib , Head Of Drug Development , Chugai Biopharmaceuticals Inc , Redchip Companies Inc , Synergy Pharmaceuticals Inc , Danaher Corporation , Life Sciences , Drug Development , Cardiff Oncology , Chief Executive Officer , Executive Chairman , Polo Like Kinase , Hepion Pharmaceuticals ,

Investegate |Tiziana Life Sci PLC Announcements | Tiziana Life Sci PLC: Director/PDMR Shareholding

A
Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
1. Obtains access to the information in a personal capacity;
2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so; ....

United Kingdom , City Of , Thomas Adams , Gabriele Cerrone , Tiziana Life Sciences , Head Of Drug Development , Redchip Companies Inc , Remuneration Committee , Life Sciences , United Kingdom Market Abuse Regulation , Kingdom Investors , Chip Companies , Investegate Announcements , Investegate Company Announcements , Tiziana Life Sci Plc , Regulatory News Service , Regulatory News Service And , ஒன்றுபட்டது கிஂக்டம் , நகரம் ஆஃப் , தாமஸ் ஆடம்ஸ் , கேப்ரியல் சிஇஆர்ஆர்ஓஎன்இ , தலை ஆஃப் மருந்து வளர்ச்சி , வாழ்க்கை அறிவியல் , ஒன்றுபட்டது கிஂக்டம் சந்தை ஒழுங்குமுறை , கிஂக்டம் முதலீட்டாளர்கள் , சிப் நிறுவனங்கள் ,

Investegate |Tiziana Life Sci PLC Announcements | Tiziana Life Sci PLC: B. Riley Virtual Oncology Investor Conference

A
Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
1. Obtains access to the information in a personal capacity;
2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so; ....

United States , United Kingdom , City Of , Kunwar Shailubhai , Gabriele Cerrone , Tiziana Life Sciences , Tiziana Life Sciences To , Redchip Companies Inc , Life Sciences , Fireside Chat , Virtual Oncology Investor Conference , Kingdom Investors , States Investors , Investegate Announcements , Investegate Company Announcements , Tiziana Life Sci Plc , Regulatory News Service , Regulatory News Service And , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , நகரம் ஆஃப் , கேப்ரியல் சிஇஆர்ஆர்ஓஎன்இ , வாழ்க்கை அறிவியல் , ஃபயர்சைட் அரட்டை , மெய்நிகர் புற்றுநோயியல் முதலீட்டாளர் மாநாடு , கிஂக்டம் முதலீட்டாளர்கள் ,